The University of Chicago Header Logo

Connection

James Howard Tonsgard to Male

Back to Details
This is a "connection" page, showing publications James Howard Tonsgard has written about Male.
James Howard Tonsgard
Connection Strength
0.156
Male
  1. Qualitative aspects of pain in children and adults with neurofibromatosis type 1 and plexiform neurofibromas: Causes, consequences, and communication. J Health Psychol. 2026 Mar; 31(4):1562-1574.
    View in: PubMed
    Score: 0.011
  2. Psychosocial functioning and determinants of the health-related quality of life in children with neurofibromatosis type 1 and cognitive impairments. J Neurooncol. 2025 Aug; 174(1):65-76.
    View in: PubMed
    Score: 0.011
  3. Effect of bevacizumab on non-target intracranial meningiomas and non-vestibular schwannomas in NF2-related schwannomatosis: NF104. J Neurooncol. 2025 Jul; 173(3):751-757.
    View in: PubMed
    Score: 0.011
  4. Development of patient reported outcome measures assessing tumor pain intensity and tumor pain interference for individuals with neurofibromatosis type 1 and plexiform neurofibromas: qualitative findings. J Patient Rep Outcomes. 2025 Apr 30; 9(1):46.
    View in: PubMed
    Score: 0.011
  5. Current Recommendations for Patient-Reported Outcome Measures Assessing Domains of Quality of Life in Neurofibromatosis Clinical Trials. Neurology. 2021 08 17; 97(7 Suppl 1):S50-S63.
    View in: PubMed
    Score: 0.009
  6. NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas. J Clin Oncol. 2021 03 01; 39(7):797-806.
    View in: PubMed
    Score: 0.008
  7. Dural Ectasia in Neurofibromatosis 1: Case Series, Management, and Review. Neurosurgery. 2020 05 01; 86(5):646-655.
    View in: PubMed
    Score: 0.008
  8. Reproducibility of cognitive endpoints in clinical trials: lessons from neurofibromatosis type 1. Ann Clin Transl Neurol. 2019 12; 6(12):2555-2565.
    View in: PubMed
    Score: 0.008
  9. Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma. J Clin Oncol. 2019 12 10; 37(35):3446-3454.
    View in: PubMed
    Score: 0.008
  10. Omega-oxidation of monocarboxylic acids in rat brain. Neurochem Res. 1998 Feb; 23(2):227-33.
    View in: PubMed
    Score: 0.007
  11. Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1. Neurology. 2016 Dec 13; 87(24):2575-2584.
    View in: PubMed
    Score: 0.006
  12. High Incidence of Noonan Syndrome Features Including Short Stature and Pulmonic Stenosis in Patients carrying NF1 Missense Mutations Affecting p.Arg1809: Genotype-Phenotype Correlation. Hum Mutat. 2015 Nov; 36(11):1052-63.
    View in: PubMed
    Score: 0.006
  13. Hyperammonemia increases serotonin 1A receptor expression in both rat hippocampus and a transfected hippocampal cell line, HN2-5. J Neurosci Res. 1995 May 01; 41(1):105-10.
    View in: PubMed
    Score: 0.006
  14. Sirolimus for progressive neurofibromatosis type 1-associated plexiform neurofibromas: a neurofibromatosis Clinical Trials Consortium phase II study. Neuro Oncol. 2015 Apr; 17(4):596-603.
    View in: PubMed
    Score: 0.005
  15. Cognitive and psychosocial phenotype of young children with neurofibromatosis-1. J Int Neuropsychol Soc. 2014 Jan; 20(1):88-98.
    View in: PubMed
    Score: 0.005
  16. The ophthalmologic presentation of NF-2 in childhood. J Pediatr Ophthalmol Strabismus. 1993 Sep-Oct; 30(5):327-30.
    View in: PubMed
    Score: 0.005
  17. Induction of (omega-1)-oxidation of monocarboxylic acids by acetylsalicylic acid. J Lipid Res. 1993 Jul; 34(7):1187-99.
    View in: PubMed
    Score: 0.005
  18. Cerebral malformations in Carpenter syndrome. Pediatr Neurol. 1993 May-Jun; 9(3):230-4.
    View in: PubMed
    Score: 0.005
  19. Expression profiling of 519 kinase genes in matched malignant peripheral nerve sheath tumor/plexiform neurofibroma samples is discriminatory and identifies mitotic regulators BUB1B, PBK and NEK2 as overexpressed with transformation. Mod Pathol. 2013 Jul; 26(7):930-43.
    View in: PubMed
    Score: 0.005
  20. Kluver-Bucy syndrome in children. Pediatr Neurol. 1987 May-Jun; 3(3):162-5.
    View in: PubMed
    Score: 0.003
  21. Serum dicarboxylic acids in patients with Reye syndrome. J Pediatr. 1986 Sep; 109(3):440-5.
    View in: PubMed
    Score: 0.003
  22. Decompressive hemicraniectomy in a 6-year-old male after unilateral hemispheric stroke. Case report and review. Pediatr Neurosurg. 2003 Apr; 38(4):181-5.
    View in: PubMed
    Score: 0.002
  23. Late-onset neurofibromatosis in a liver transplant recipient. Int J Dermatol. 2000 May; 39(5):376-9.
    View in: PubMed
    Score: 0.002
  24. Descriptive analysis of tibial pseudarthrosis in patients with neurofibromatosis 1. Am J Med Genet. 1999 Jun 11; 84(5):413-9.
    View in: PubMed
    Score: 0.002
  25. A novel disease with deficiency of mitochondrial very-long-chain acyl-CoA dehydrogenase. Biochem Biophys Res Commun. 1993 Mar 31; 191(3):1369-72.
    View in: PubMed
    Score: 0.001
  26. Induction of omega-oxidation of monocarboxylic acids in rats by acetylsalicylic acid. J Clin Invest. 1991 Dec; 88(6):1865-72.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.